S&P 5007,785.76▼0.2% Nasdaq26,729.16▼0.3% Dow53,732.41▼0.2% Russell 2K3,068.42▲0.5% 10-Yr4.70%+6bp VIX14.25−0.38 WTI$82.40▲1.4% Gold$4,432.00▲1.6% EUR/USD1.157▲0.4% BTC$78,896▲0.4% Nikkei68,309▲1.2%
At close · Fri, Aug 14, 2026
Daily Market Updates.

Earnings

Home›Earnings›Previews›Eli Lilly price target raised after beat-and-raise qua…

Eli Lilly price target raised after beat-and-raise quarter

CNBC Earnings said strength in the company’s GLP-1 business indicates the stock may have further upside.

Reported · Written up by our desk · Previews

Eli Lilly’s stock price target was increased following another beat-and-raise quarter, according to CNBC Earnings.

The outlet pointed to ongoing strength in the company’s GLP-1 business, arguing it suggests the shares still have more room to run.

The update frames the latest results as confirmation of momentum in Eli Lilly’s GLP-1 franchise.

← Newer storyTreasuries hold steady after ISM impact, fuel prices steady

More like this

EarningsOptions traders expect Salesforce shares to rise after earnings
EarningsNvidia shares jump after earnings beat and guides $108B in revenue
EarningsWilliams-Sonoma stock holds key support after raised Q2 guidance
EarningsAlcoa breaks ground on Western Australia facility to extract gallium
EarningsOura Health targets about $16 billion valuation in US IPO

Sources

CNBC EarningsWe're increasing our Eli Lilly price target after another beat-and-raise quarter

Get the close, explained.

One email every trading day: what moved, why it moved, and what's on deck tomorrow. Read in 3 minutes.

Free. Unsubscribe anytime.